The Role of B Cells in Primary Progressive Multiple Sclerosis
Abstract The success of ocrelizumab in reducing confirmed disability accumulation in primary progressive multiple sclerosis (PPMS) via CD20-targeted depletion implicates…
Abstract The success of ocrelizumab in reducing confirmed disability accumulation in primary progressive multiple sclerosis (PPMS) via CD20-targeted depletion implicates…
Abstract Philadelphia chromosome (Ph) results from a translocation between the breakpoint cluster region (BCR) gene on chromosome 9 and ABL…
Abstract Objective: Adverse events of drug therapy Background: Rituximab is a chimeric monoclonal antibody to CD20 that is used to…